Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4445897
Max Phase: Preclinical
Molecular Formula: C49H85N3O15
Molecular Weight: 956.22
Molecule Type: Unknown
Associated Items:
ID: ALA4445897
Max Phase: Preclinical
Molecular Formula: C49H85N3O15
Molecular Weight: 956.22
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCC(=O)N(C)C(C[C@H]1C[C@@H](C)C(=O)/C=C/C(C)=C/[C@H](CO[C@H]2O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]2OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]1O)C(=O)NC(C)(C)C
Standard InChI: InChI=1S/C49H85N3O15/c1-16-18-37(55)52(13)33(46(60)50-49(8,9)10)23-31-22-27(4)34(53)20-19-26(3)21-32(25-63-48-45(62-15)44(61-14)41(58)30(7)65-48)36(17-2)66-38(56)24-35(54)28(5)43(31)67-47-42(59)39(51(11)12)40(57)29(6)64-47/h19-21,27-33,35-36,39-45,47-48,54,57-59H,16-18,22-25H2,1-15H3,(H,50,60)/b20-19+,26-21+/t27-,28+,29-,30+,31-,32-,33?,35-,36-,39+,40-,41+,42-,43-,44+,45+,47+,48+/m1/s1
Standard InChI Key: IHKALYHSFAZMRF-PLHNQZTASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 956.22 | Molecular Weight (Monoisotopic): 955.5981 | AlogP: 2.91 | #Rotatable Bonds: 15 |
Polar Surface Area: 232.32 | Molecular Species: NEUTRAL | HBA: 16 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.54 | CX Basic pKa: 7.94 | CX LogP: 3.14 | CX LogD: 2.49 |
Aromatic Rings: 0 | Heavy Atoms: 67 | QED Weighted: 0.15 | Np Likeness Score: 1.17 |
1. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
Source(1):